Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023

塞栓保護デバイスの世界市場予測(~2023年):遠位フィルター、遠位咬合、近位閉塞

◆タイトル:Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023
◆商品コード:MAM-MD-6012
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年2月16日
◆ページ数:174
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥598,900見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥704,900見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥863,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、塞栓保護デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、材料別分析、用途別分析、疾患別分析、塞栓保護デバイスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Global embolic protection devices market projected to grow at a CAGR of 8.3%”The global embolic protection devices market is projected to reach USD 604.9 million by 2023 from USD 405.5 million in 2018, at a CAGR of 8.3% during the forecast period. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. However, product failure and recalls may restrain market growth to a certain extent.
“By type & material, the distal filters market & nitinol market held the largest market share in 2017”
By type, the global embolic protection devices market is segmented into distal filter devices, distal occlusion devices & proximal occlusion devices. By material, the global embolic protection devices market is segmented into plastic nitinol and polyurethane. In 2017, the distal filters segment dominated the embolic protection devices market by type and Nitinol dominated the embolic protection material market.
“By indication, the transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period”
On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. The transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by factors such as growing geriatric population, increasing obese population, increasing prevalence of aortic stenosis in heart patients, and rising demand for minimally invasive procedures.
“North America is expected to grow at the largest share during the forecast period (2018-2023)”
North America dominated the embolic protection devices market in 2017, followed by Europe. In North America, the US is expected to hold the largest share of the embolic protection devices market due to the rising prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding to develop novel products, and the strong presence of device manufacturers in the country.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–45%, Tier 2–30% and Tier 3–25%
• By Designation – C-level–45%, Director Level–32%, Others–23%
• By Region – North America–46%, Europe–27%, Asia-Pacific–20%, Latin America–4%, Middle East & Africa- 3%

The major players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).
Research Coverage:
The embolic protection devices market in this report is segmented by type & material, application, indication, end user, and region. It provides detailed information regarding major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers, acquisitions, product development, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the embolic protection devices market.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—market share analysis of top players and company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the embolic protection devices market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest industry statistics and trends, allowing buyers to identify the high-growth product segments, potential customers, and suppliers hence driving revenue growth and profitability.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on embolic devices offered by the top players in the global embolic protection devices market

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the embolic protection devices market

• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for embolic protection devices market across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global embolic protection devices market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global embolic protection devices market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.4 YEARS CONSIDERED FOR THE STUDY 16
1.5 CURRENCY 17
1.6 LIMITATIONS 17
1.7 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY SOURCES 19
2.1.1.1 Key data from secondary sources 19
2.1.2 PRIMARY SOURCES 20
2.1.2.1 Key data from primary sources 20
2.1.2.2 Key industry insights 21
2.1.2.3 Breakdown of primary interviews 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 22
2.2.2 TOP-DOWN APPROACH 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 32
4.1 ATTRACTIVE OPPORTUNITIES IN THE EMBOLIC PROTECTION DEVICES MARKET 32
4.2 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION AND COUNTRY 33
4.3 GEOGRAPHIC SNAPSHOT OF THE EMBOLIC PROTECTION DEVICES MARKET 34
4.4 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 35
4.5 EMBOLIC PROTECTION DEVICES MARKET: REGIONAL MIX 35

5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 37
5.2.1.1 Rising incidence of cardiovascular & neurovascular diseases 37
5.2.1.2 Funding and investments for r&d on embolic protection devices 39
5.2.1.3 Technological advancements 39
5.2.1.4 Rising demand for minimally invasive procedures 40
5.2.2 RESTRAINT 40
5.2.2.1 Product failure and recalls 40
5.2.3 OPPORTUNITIE 41
5.2.3.1 Growth opportunities in emerging markets 41
5.2.4 CHALLENGES 42
5.2.4.1 Stringent regulatory scenario and unfavorable government policies 42
5.2.4.2 Dearth of skilled professionals 43
6 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE & MATERIAL 44
6.1 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE 45
6.1.1 DISTAL FILTER DEVICES 46
6.1.2 DISTAL OCCLUSION DEVICES 49
6.1.3 PROXIMAL OCCLUSION DEVICES 51
6.2 EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL 53
6.2.1 NITINOL 54
6.2.2 POLYURETHANE 55
7 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION 56
7.1 INTRODUCTION 57
7.2 CARDIOVASCULAR DISEASES 58
7.3 NEUROVASCULAR DISEASES 60
7.4 PERIPHERAL VASCULAR DISEASES 61
8 EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION 63
8.1 INTRODUCTION 64
8.2 PERCUTANEOUS CORONARY INTERVENTION 65
8.3 CAROTID ARTERY DISEASES 66
8.4 SAPHENOUS VEIN GRAFT DISEASE 67
8.5 TRANSCATHER AORTIC VALVE REPLACEMENT 68
8.6 OTHER INDICATIONS 69

9 EMBOLIC PROTECTION DEVICES MARKET, BY END USER 70
9.1 INTRODUCTION 71
9.2 HOSPITALS 72
9.3 AMBULATORY SURGICAL CENTERS 74
10 EMBOLIC PROTECTION DEVICES MARKET, BY REGION 76
10.1 INTRODUCTION 77
10.2 NORTH AMERICA 79
10.2.1 US 84
10.2.2 CANADA 87
10.3 EUROPE 90
10.3.1 GERMANY 95
10.3.2 FRANCE 98
10.3.3 UK 101
10.3.4 SPAIN 104
10.3.5 ITALY 107
10.3.6 REST OF EUROPE 110
10.4 ASIA PACIFIC 113
10.4.1 JAPAN 118
10.4.2 CHINA 121
10.4.3 INDIA 124
10.4.4 REST OF ASIA PACIFIC 127
10.5 LATIN AMERICA 130
10.6 MIDDLE EAST AND AFRICA 133
11 COMPETITIVE LANDSCAPE 137
11.1 OVERVIEW 137
11.2 RANKING FOR PLAYERS, 2017 138
11.3 COMPETITIVE SCENARIO 140
11.3.1 ACQUISITIONS 140
11.3.2 PRODUCT LAUNCHES 140
11.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 141
11.3.4 EXPANSIONS 141

12 COMPANY PROFILES 142
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
12.1 MEDTRONIC 142
12.2 ABBOTT LABORATORIES 146
12.3 BOSTON SCIENTIFIC 149
12.4 CORDIS (A CARDINAL HEALTH COMPANY) 152
12.5 CONTEGO MEDICAL 155
12.6 W. L. GORE & ASSOCIATES 156
12.7 SILK ROAD MEDICAL 157
12.8 CLARET MEDICAL 158
12.9 ALLIUM MEDICAL SOLUTIONS 159
12.10 ANGIOSLIDE 160
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX 161
13.1 INSIGHTS OF INDUSTRY EXPERTS 161
13.2 DISCUSSION GUIDE 162
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 166
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 168
13.5 AVAILABLE CUSTOMIZATIONS 170
13.6 RELATED REPORTS 171
13.7 AUTHOR DETAILS 172

LIST OF TABLES

TABLE 1 EMBOLIC PROTECTION DEVICES MARKET: (IMPACT ANALYSIS) 37
TABLE 2 PRODUCT APPROVALS IN THE EMBOLIC PROTECTION DEVICES MARKET,
2014–2017 40
TABLE 3 PRODUCT RECALLS IN THE EMBOLIC PROTECTION DEVICES MARKET (2011–2016) 41
TABLE 4 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 45
TABLE 5 EMBOLIC PROTECTION DEVICES MARKET, BY VOLUME,
2016–2023 (THOUSAND UNITS) 46
TABLE 6 APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF DISTAL FILTER DEVICES 47
TABLE 7 DISTAL FILTER DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 47
TABLE 8 DISTAL FILTER DEVICES MARKET, BY VOLUME, 2016–2023 (THOUSAND UNITS) 48
TABLE 9 APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF DISTAL OCCLUSION DEVICES 49
TABLE 10 DISTAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 50
TABLE 11 DISTAL OCCLUSION DEVICES MARKET, BY VOLUME,
2016–2023 (THOUSAND UNITS) 50
TABLE 12 APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF PROXIMAL OCCLUSION DEVICES 51
TABLE 13 PROXIMAL OCCLUSION DEVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 52
TABLE 14 PROXIMAL OCCLUSION DEVICES MARKET, BY VOLUME,
2016–2023 (THOUSAND UNITS) 52
TABLE 15 EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 53
TABLE 16 NITINOL EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 54
TABLE 17 POLYURETHANE EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 55
TABLE 18 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 57
TABLE 19 EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES 58
TABLE 20 EMBOLIC PROTECTION DEVICES MARKET FOR CARDIOVASCULAR DISEASES,
BY COUNTRY, 2016–2023 (USD MILLION) 59
TABLE 21 EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF NEUROVASCULAR DISEASES 60
TABLE 22 EMBOLIC PROTECTION DEVICES MARKET FOR NEUROVASCULAR DISEASES,
BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 23 EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF PERIPHERAL VASCULAR DISEASES 62
TABLE 24 EMBOLIC PROTECTION DEVICES MARKET FOR PERIPHERAL VASCULAR DISEASES, BY COUNTRY, 2016–2023 (USD MILLION) 62
TABLE 25 EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 64
TABLE 26 EMBOLIC PROTECTION DEVICES MARKET FOR PERCUTANEOUS CORONARY INTERVENTION, BY COUNTRY, 2016–2023 (USD MILLION) 65
TABLE 27 EMBOLIC PROTECTION DEVICES MARKET FOR CAROTID ARTERY DISEASES,
BY COUNTRY, 2016–2023 (USD MILLION) 66
TABLE 28 EMBOLIC PROTECTION DEVICES MARKET FOR SAPHENOUS VEIN GRAFT DISEASE, BY COUNTRY, 2016–2023 (USD MILLION) 67
TABLE 29 EMBOLIC PROTECTION DEVICES MARKET FOR TAVR, BY COUNTRY,
2016–2023 (USD MILLION) 68
TABLE 30 EMBOLIC PROTECTION DEVICES MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 69
TABLE 31 EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 71
TABLE 32 EMBOLIC PROTECTION DEVICES MARKET FOR HOSPITALS, BY COUNTRY,
2016–2023 (USD MILLION) 73
TABLE 33 EMBOLIC PROTECTION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION) 75
TABLE 34 GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 78
TABLE 35 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 81
TABLE 36 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 81
TABLE 37 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 82
TABLE 38 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 82
TABLE 39 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION) 83
TABLE 40 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 83
TABLE 41 US: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 84
TABLE 42 US: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 85
TABLE 43 US: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 85
TABLE 44 US: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 86
TABLE 45 US: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 86
TABLE 46 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 87
TABLE 47 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 88
TABLE 48 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 88
TABLE 49 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 89
TABLE 50 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 89
TABLE 51 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 92
TABLE 52 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 92
TABLE 53 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 93
TABLE 54 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 93
TABLE 55 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 94
TABLE 56 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 94
TABLE 57 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 96
TABLE 58 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 96
TABLE 59 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 97
TABLE 60 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 97
TABLE 61 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 98
TABLE 62 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 99
TABLE 63 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 99
TABLE 64 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 100
TABLE 65 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 100
TABLE 66 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 101
TABLE 67 UK: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 102
TABLE 68 UK: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 102
TABLE 69 UK: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 103
TABLE 70 UK: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 103
TABLE 71 UK: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 104
TABLE 72 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 105
TABLE 73 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 105
TABLE 74 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 106
TABLE 75 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 106
TABLE 76 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 107
TABLE 77 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 107
TABLE 78 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 108
TABLE 79 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 108
TABLE 80 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 109
TABLE 81 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 109
TABLE 82 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 110
TABLE 83 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 111
TABLE 84 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 111
TABLE 85 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 112
TABLE 86 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 112
TABLE 87 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 115
TABLE 88 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 115
TABLE 89 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 116
TABLE 90 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 116
TABLE 91 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 117
TABLE 92 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 117
TABLE 93 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 118
TABLE 94 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 119
TABLE 95 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 119
TABLE 96 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 120
TABLE 97 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 120
TABLE 98 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 122
TABLE 99 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 122
TABLE 100 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 123
TABLE 101 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 123
TABLE 102 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 124
TABLE 103 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 125
TABLE 104 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 125
TABLE 105 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 126
TABLE 106 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 126
TABLE 107 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 127
TABLE 108 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 128
TABLE 109 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 128
TABLE 110 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 129
TABLE 111 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 129
TABLE 112 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 130
TABLE 113 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 131
TABLE 114 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL,
2016–2023 (USD MILLION) 131
TABLE 115 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 132
TABLE 116 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION,
2016–2023 (USD MILLION) 132
TABLE 117 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2016–2023 (USD MILLION) 133
TABLE 118 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 134
TABLE 119 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION) 134
TABLE 120 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 135
TABLE 121 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION) 135
TABLE 122 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION) 136
TABLE 123 RANK OF COMPANIES IN THE GLOBAL EMBOLIC PROTECTION DEVICES
MARKET, 2017 138
TABLE 124 KEY ACQUISITIONS, JANUARY 2015 – DECEMBER 2017 140
TABLE 125 KEY PRODUCT LAUNCHES, JANUARY 2015– DECEMBER 2017 140
TABLE 126 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS,
JANUARY 2015 – DECEMBER 2017 141
TABLE 127 KEY EXPANSIONS, JANUARY 2015 – DECEMBER 2017 141


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 18
FIGURE 2 DATA TRIANGULATION 24
FIGURE 3 EMBOLIC PROTECTION DEVICES MARKET, BY PRODUCT TYPE,
2018 VS. 2023 (USD MILLION) 26
FIGURE 4 EMBOLIC PROTECTION DEVICES MARKET, BY PRODUCT MATERIAL,
2018 VS. 2023 (USD MILLION) 27
FIGURE 5 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION,
2018 VS. 2023 (USD MILLION) 28
FIGURE 6 PERCUTANEOUS CORONARY INTERVENTION SEGMENT TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD 29
FIGURE 7 EMBOLIC PROTECTION DEVICES MARKET, BY END USER,
2018 VS. 2023 (USD MILLION) 30
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE EMBOLIC PROTECTION DEVICES MARKET 31
FIGURE 9 RISING INCIDENCE OF CARDIOVASCULAR AND NEUROVASCULAR DISEASES IS DRIVING MARKET GROWTH 32
FIGURE 10 JAPAN ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017 33
FIGURE 11 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE EMBOLIC PROTECTION DEVICES MARKET IN 2017 34
FIGURE 12 DISTAL FILTER DEVICES WILL CONTINUE TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET IN 2018-2023 35
FIGURE 13 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 35
FIGURE 14 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035 38
FIGURE 15 DISTAL FILTER DEVICES TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD 45
FIGURE 16 NITINOL IS PROJECTED TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD 53
FIGURE 17 CARDIOVASCULAR DISEASES TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD 57
FIGURE 18 PERCUTANEOUS CORONARY INTERVENTION SEGMENT TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD 64
FIGURE 19 EMBOLIC PROTECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 77
FIGURE 20 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT 80
FIGURE 21 EUROPE: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT 91
FIGURE 22 APAC: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT 114
FIGURE 23 KEY DEVELOPMENTS IN THE EMBOLIC PROTECTION DEVICES MARKET BETWEEN 2014 AND 2017 137
FIGURE 24 MEDTRONIC: COMPANY SNAPSHOT 142
FIGURE 25 ABBOTT LABORATORIES: COMPANY SNAPSHOT 146
FIGURE 26 BOSTON SCIENTIFIC: COMPANY SNAPSHOT 149
FIGURE 27 CARDINAL HEALTH: COMPANY SNAPSHOT 152
FIGURE 28 ALLIUM MEDICAL SOLUTIONS: COMPANY SNAPSHOT 159


【レポートのキーワード】

塞栓保護デバイス、医療機器、遠位フィルター、遠位咬合、近位閉塞

★調査レポート[塞栓保護デバイスの世界市場予測(~2023年):遠位フィルター、遠位咬合、近位閉塞] ( Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023 / MAM-MD-6012) 販売に関する免責事項
[塞栓保護デバイスの世界市場予測(~2023年):遠位フィルター、遠位咬合、近位閉塞] ( Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023 / MAM-MD-6012) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆